QualiPhi^®: A new standard for DNA amplification

Sygnis includes in its portfolio a new method for DNA amplification based on phi29 DNA polymerase chimeras and an improved reaction buffer. The market size of DNA amplification is estimated to be up to 70M € per year.

DNA amplification is a key first step in many methods used in molecular biology laboratories, for example in medical research, diagnostics, personalized medicine and forensics.

QualiPhi^® is expected to become the new standard of DNA amplification due to its higher efficiency, between 1000 - 10000 times, in amplifying DNA than the current products in the market.